Determining Patterns In Trial Experiences of Diabetic Neuropathy Patients
Study Details
Study Description
Brief Summary
Historically, participation in clinical studies is highly skewed towards particular demographic groups of people.
This study will invite several participants to gather a wide range of information on clinical trial experiences for diabetic neuropathy patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of diabetic neuropathy.
The data collected from this study will help improve future outcomes for all diabetic neuropathy patients as well as those in under-represented demographic groups.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Outcome Measures
Primary Outcome Measures
- Number of patients who decide to enroll in an diabetic neuropathy clinical trial [3 months]
- Rate of patients who remain in diabetic neuropathy clinical trial to trial completion [12 months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient plans to participate in an interventional clinical trial for the condition of diabetic neuropathy
-
Patient has been diagnosed with a type of diabetic neuropathy
-
Patient is a minimum of 18 years of age
-
Patient has access to a home internet connection in order to provide regular updates through the course of the study
Exclusion Criteria:
-
Patient is not able to provide consistent digital updates as per study requirements
-
Patient does not complete or agree to terms outlined in the Informed Consent Form
-
Patient has an ECOG score of 4 or higher
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Power Life Sciences Inc.
Investigators
- Study Director: Michael B Gill, Power Life Sciences Inc.
Study Documents (Full-Text)
More Information
Publications
- Clark LT, Watkins L, Piña IL, Elmer M, Akinboboye O, Gorham M, Jamerson B, McCullough C, Pierre C, Polis AB, Puckrein G, Regnante JM. Increasing Diversity in Clinical Trials: Overcoming Critical Barriers. Curr Probl Cardiol. 2019 May;44(5):148-172. doi: 10.1016/j.cpcardiol.2018.11.002. Epub 2018 Nov 9. Review. Erratum in: Curr Probl Cardiol. 2021 Mar;46(3):100647.
- Pfeifer MA, Schumer MP. Clinical trials of diabetic neuropathy: past, present, and future. Diabetes. 1995 Dec;44(12):1355-61. Review.
- Rosenberger DC, Blechschmidt V, Timmerman H, Wolff A, Treede RD. Challenges of neuropathic pain: focus on diabetic neuropathy. J Neural Transm (Vienna). 2020 Apr;127(4):589-624. doi: 10.1007/s00702-020-02145-7. Epub 2020 Feb 8. Review.
- 8874740